InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: zoriden post# 9428

Tuesday, 03/04/2014 12:56:06 PM

Tuesday, March 04, 2014 12:56:06 PM

Post# of 48316
Yes addition of PD-1/PDL-1 to Melanoma Phase2B is super huge. IMO $ONCS Phase2B Melanoma with addition of PD-1/PDL-1 to PIL-12+EP may very well qualify $ONCS Phase2B Melanoma as a Pivotal trial from which continuing super results would enable the FDA to award a Commercial BLA license to $ONCS Melanoma. Just saying, not for certain as it will be up to the FDA . At the very least super results for $ONCS Phase2B could mean a much smaller and less costly Phase3.